1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane
Structure Info
- Chemspace ID
- CSSB02229500790 (In-Stock Building Blocks)
- IUPAC Name
- 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane
- Mol formula
- C20H30BNO3
- Mol weight
- 343 Da
- Catalog Number(s)
- BBLS02229500790, BBV-288333213, EN300-55165970, bbls02229500790
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.56
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.65
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane (C20H30BNO3) - CSSB02229500790](/st/structure/200/c323fbd8d45c2188306a14a408fcc5c3/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCCCC1.png "C20H30BNO3")
- Zoom the structure
- CSSB02229500790
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of rac-(1R,6R)-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-azabicyclo[4.2.0]octane - CSSB21331650469](/st/structure/200/a270e2b89698f840da511427cc974972/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CC%255BC%2540H%255D2C1%2B%257C%25261%253A20%252C23%252Cr%257C.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB02229494050](/st/structure/200/3a64b9a1e7d70d1627e5df84fcfa78fa/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC2CCCC12.png)
![Chemical structure of rac-(3aR,6aR)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB21332841571](/st/structure/200/591f342d23d3daa349808c4c1d4360cb/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CCC%255BC%2540%2540H%255D12%2B%257C%25261%253A20%252C24%252Cr%257C.png)
![Chemical structure of rac-(1R,6R)-7-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-7-azabicyclo[4.2.0]octane - CSSB21331611844](/st/structure/200/e793dfb030a2b51e155bef020eec68c7/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1C%255BC%2540H%255D2CCCC%255BC%2540%2540H%255D12%2B%257C%25261%253A19%252C24%252Cr%257C.png)
Similarity Analogs
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azepane - CSSB02195991377](/st/structure/200/848db6b26cd4308fbbf8ce9eaba6da5a/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB00020613837](/st/structure/200/f6a816dd6085320c66e5f6198960426e/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB00000062365](/st/structure/200/e8d1292d78042a13303164e90789e718/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB00010725094](/st/structure/200/ac337900ce77096ee5111ca3dbcbcc73/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC1.png)
![Chemical structure of 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-1,4-oxazocane - CSSB14993861276](/st/structure/200/f4645be8ae3ae6ff0461e044de431bf5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCOCC1.png)
![Chemical structure of 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-1,4-oxazepane - CSSB02195989209](/st/structure/200/d7de58811a3ab07fd523fb789dd93913/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCOCC1.png)
![Chemical structure of 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]morpholine - CSSB00015191535](/st/structure/200/b0e02387193158699adbf95d83b7d7dc/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCOCC1.png)
